Nanoparticle-drug conjugates represent a convergence of nanotechnology and pharmacology, designed to improve the selectivity, pharmacokinetics and therapeutic index of anticancer agents. By covalently ...
Antibody-based cancer therapies have clear advantages over chemotherapeutic drugs thanks to their high specificity and low risk of side effects. However, it can be difficult to identify targetable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results